Literature DB >> 9234793

Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection.

R Hernandez-Pando1, L Pavön, K Arriaga, H Orozco, V Madrid-Marina, G Rook.   

Abstract

Mycobacteria are ubiquitous in the environment, but they are not part of the normal human microbial flora. It has been suggested that variable contact with mycobacteria can influence susceptibility to mycobacterial pathogens and the efficacy of subsequent Mycobacterium bovis BCG vaccination. To test this, mice were immunized with high or low doses of an environmental saprophyte, M. vaccae, that is intensely immunogenic as an autoclaved preparation. Two months later, they received an intratracheal challenge with M. tuberculosis H37Rv. Recipients of a low Th1-inducing dose (10(7) organisms) were partially protected and maintained a high ratio of interleukin 2 (IL-2)-positive to IL-4-positive cells in the perivascular, peribronchial, and granulomatous areas of the lung, whereas in unimmunized controls the IL-4-positive cells increased markedly between days 21 and 28. In contrast, recipients of the high dose (10(9) organisms), which primes Th2 as well as Th1 cytokine production, died more rapidly than unimmunized controls and showed massive pneumonia from day 7. The ratio of IL-2-positive to IL-4-positive cells in all compartments of the lung rapidly fell to 1 by day 14 for these animals. These events correlated with cytokine mRNA profiles and with increases in the local toxicity of tumor necrosis factor alpha (TNF-alpha), demonstrable only when a major Th2 component was present. These data indicate that cross-reactive epitopes present in an environmental saprophyte can evoke either protective responses or responses that increase susceptibility to M. tuberculosis. The latter are associated with the presence of a Th2 component and increased sensitivity to TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234793      PMCID: PMC175470          DOI: 10.1128/iai.65.8.3317-3327.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  The pathogenesis of tuberculosis.

Authors:  G A Rook; R Hernandez-Pando
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

Review 2.  Variation in protection by BCG: implications of and for heterologous immunity.

Authors:  P E Fine
Journal:  Lancet       Date:  1995-11-18       Impact factor: 79.321

Review 3.  Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection.

Authors:  B R Bloom; J Flynn; K McDonough; Y Kress; J Chan
Journal:  Immunobiology       Date:  1994-10       Impact factor: 3.144

4.  Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis?

Authors:  R Hernandez-Pando; H Orozco; J Honour; P Silva; R Leyva; G A Rook
Journal:  FEMS Immunol Med Microbiol       Date:  1995-09

5.  Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.

Authors:  C H Ladel; S Daugelat; S H Kaufmann
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

6.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

7.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

Authors:  Y Tanaka; C T Morita; Y Tanaka; E Nieves; M B Brenner; B R Bloom
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

8.  Cytokine regulation of disease progression in leprosy and tuberculosis.

Authors:  G Kaplan
Journal:  Immunobiology       Date:  1994-10       Impact factor: 3.144

9.  The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance.

Authors:  R Hernandez-Pando; G A Rook
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

10.  T-cell cytokine responses in human infection with Mycobacterium tuberculosis.

Authors:  M Zhang; Y Lin; D V Iyer; J Gong; J S Abrams; P F Barnes
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  53 in total

Review 1.  Effective vaccination against tuberculosis-a new ray of hope.

Authors:  J M Grange
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis.

Authors:  Rogelio Hernandez Pando; Leon Diana Aguilar; Issar Smith; Riccardo Manganelli
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

3.  Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.

Authors:  Timothy Lahey; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Mecky Matee; Richard Waddell; Lillian Mtei; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

4.  Effect of low-dose antigen exposure on development of immunity to Helicobacter pylori infection in mice.

Authors:  F J Radcliff; R L Ferrero
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Intragranulomatous necrosis in pulmonary granulomas is not related to resistance against Mycobacterium tuberculosis infection in experimental murine models induced by aerosol.

Authors:  Evelyn Guirado; Sergi Gordillo; Olga Gil; Jorge Díaz; Gustavo Tapia; Cristina Vilaplana; Vicenç Ausina; Pere-Joan Cardona
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

6.  Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design.

Authors:  Johan Vekemans; Martin O C Ota; Jackson Sillah; Katherine Fielding; Mark R Alderson; Yasir A W Skeiky; Wilfried Dalemans; Keith P W J McAdam; Christian Lienhardt; Arnaud Marchant
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

Authors:  R A Fabre; T M Pérez; L D Aguilar; M J Rangel; I Estrada-Garcìa; R Hernández-Pando; S Estrada Parra
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

8.  The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; M De La Luz Streber; H Orozco; K Arriaga; L Pavon; S A Al-Nakhli; G A Rook
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

9.  Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model.

Authors:  J Dormans; M Burger; D Aguilar; R Hernandez-Pando; K Kremer; P Roholl; S M Arend; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

10.  Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.

Authors:  Rogelio Hernández-Pando; Diana Aguilar; Hector Orozco; Yuriria Cortez; Laura Rosa Brunet; Graham A Rook
Journal:  Clin Vaccine Immunol       Date:  2008-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.